#109 - Autoimmune & Inflammatory Diseases (Liliana Massis‪)‬ Future Hacker (English)

In this engaging episode we explore the intriguing world of immunology with our guest Liliana Moura Massis, a leading Scientist in autoimmune diseases. Liliana recounts her inspiring journey from Brazil to Silicon Valley, facing challenges and seizing opportunities in the biomedical sciences. She reflects on the brain drain from Brazil, offers advice to emerging scientists, and discusses her transition from academia to industry, highlighting the differences and her innovative approach to immunology research. The episode also covers the future of autoimmune and inflammatory disease treatment, the promise of personalized medicine through technological advancements, and lessons from the Typhoid Mary story for public health. This episode is a compelling listen for anyone interested in the confluence of technology, health, and science, showcasing Liliana's remarkable journey and her visionary outlook on the future of healthcare.

🎧 LISTEN TO THE MAIN PODCAST PLAYERS:

🔊 SPOTIFY: https://lnkd.in/ey6Jy6u

🔊 GOOGLE: https://lnkd.in/eFa649q

🔊 APPLE: https://podcasts.apple.com/us/podcast/future-hacker/id1659516528

👉 SUBSCRIBE OUR CHANNEL: https://www.youtube.com/channel/UCf0pQjeMwZHFZXI-Kd5qF7A?sub_confirmation=1

👉 INSTAGRAM: https://www.instagram.com/future_hacker.co/

👉 FACEBOOK: https://www.facebook.com/futurehacker.fb

👉 TWITTER: https://twitter.com/TheFutureHacker

👉 LINKEDIN: https://www.linkedin.com/company/future-hacker/

👉 SITE: https://www.futurehacker.co

 

# #futurehacker #FutureHackerPodcast #Immunology #BiomedicalScience #SiliconValley #AcademiaToIndustry #AutoimmuneDiseases #PersonalizedMedicine #PublicHealth #ScienceCareer #TechnologyInHealthcare Disclaimer: The opinions and views expressed by our guests are their own and do not necessarily reflect Future Hacker views. We do not take responsibility for the accuracy of any information provided during the interviews. Listeners are encouraged to verify the information independently.
See omnystudio.com/listener for privacy information.